Cognition Therapeutics gets Nasdaq extension to Sept 8, 2025; transfer to Capital Market

COGNITION THERAPEUTICS INC

Received Nasdaq extension notice on March 12, 2025, granting 180 additional days until Sept 8, 2025 to regain $1.00 minimum bid price.
Common stock will transfer from Nasdaq Global Market to Nasdaq Capital Market effective March 14, 2025.
Company will consider options including a reverse stock split to regain compliance.
If not compliant by Sept 8, 2025, Nasdaq will initiate delisting; company may appeal.
Bid price has been below $1.00 for over 30 consecutive business days as of Sep 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.